RYZENDAK
LIVE

Serial Number

79211206

Owner

NOVARTIS AG

Filing Date

May 9, 2017

Add to watchlist:

No watchlists yet
View on USPTO

RYZENDAK Trademark

Serial Number: 79211206 • Registration: 5319723

RYZENDAK is a trademark filed by NOVARTIS AG on May 9, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 9, 2017

Registration Date

October 31, 2017

Published for Opposition

August 15, 2017

Cancellation Date

November 17, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 30, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 30, 2021 DETH
NOTIFICATION PROCESSED BY IB
Feb 23, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2017 FICS
FINAL DISPOSITION PROCESSED
Dec 14, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 30, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2017 R.PR
PUBLISHED FOR OPPOSITION
Aug 15, 2017 PUBO
NOTICE OF PUBLICATION
Jul 26, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
Jul 11, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2017 CNSA
ASSIGNED TO EXAMINER
Jul 7, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 5, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 30, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 29, 2017 SDRC